ArticleOncology research2024

ROR2 promotes invasion and chemoresistance of triple-negative breast cancer cells by activating PI3K/AKT/mTOR signaling.

Xia DA et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.